Clinical trial Recruiting at 1 site Observational Ages 18 and up

Investigating inflammation's role in heart disease and diabetes

Official title: Inflammation: a Key Contributor to Heart Disease and Diabetes?

Run by University of Aarhus · NCT06752018 · Data updated 2026-11-12

This study is testing how inflammation affects heart disease and diabetes in people who are healthy compared to those who are severely obese, to see if it can help identify who might benefit from new treatments.

More Obesity trials

Quick facts

Study typeObservational
Ages18 Years and up
SexAll
Enrollment250 (estimated)
SponsorUniversity of Aarhus
Academic / other
Locations1 site (Aarhus)
StatusRecruiting
StartedJanuary 30, 2025
Main results expectedDecember 2030
Study endsDecember 2030
Registry record updatedFebruary 3, 2025
Trial IDNCT06752018 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates include men and women over 18 years old with a BMI of 35-50 kg/m2 who are scheduled for gastric bypass surgery, as well as healthy individuals with a BMI of 18.5-24.9 kg/m2.

Probably not a fit

Patients with active cancer, significant gastrointestinal problems, or underlying inflammatory diseases may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to evaluate the inflammatory response associated with cardiometabolic diseases, particularly focusing on obesity and type 2 diabetes. It involves two groups: healthy volunteers and severely obese patients undergoing weight-loss surgery. Participants will undergo baseline testing, provide tissue samples during surgery, and participate in follow-up assessments to track changes over time. The study seeks to develop a predictive model to identify individuals most likely to benefit from anti-inflammatory treatments, thereby supporting personalized therapeutic strategies.

Why it matters

Potential benefit: If successful, this study could lead to personalized treatments that effectively reduce inflammation and improve outcomes for patients with obesity and cardiometabolic diseases.

How similar studies have gone: Other studies have shown promise in understanding the relationship between inflammation and cardiometabolic diseases, but this specific approach is novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Individuals willing and able to give appropriate oral and written informed consent
* Men and women over 18 years of age.
* Correct body mass index (BMI) (Lean controls: 18.5-24.9 kg/m2. Obese gastric bypass patients: 35-50 kg/m2)

Exclusion Criteria:

* The individual does not follow instructions given in the research study.
* Pregnancy.
* Significant gastrointestinal problems.
* Use of tobacco.
* The individual consumed alcohol within two days prior to the study visit
* Active cancer within 5 years.
* Use of dietary supplements that impact the inflammatory resolution process (e.g., fish oils), and the person is not willing to discontinue the use of the supplements 1 week prior to the visits.
* Underlying cardiometabolic disease, or medication related to such disease (e.g., blood pressure medication, insulin to treat diabetes, etc.).
* Underlying inflammatory disease, or medication related to such disease.
* The individual states that they have increased bleeding tendency or are using anti-coagulant (blood-thinning) medication.
* For obese patients only: The individual has lost more than 8% of his/her body weight since their clinical referral for surgery or has lost more than 3% of his/her body weight in the 4 months leading up to surgery.

Where it's running

  • Steno Diabetes Center Aarhus
    Aarhus, Denmark
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.